COVID-19 Symptoms Are Attenuated in Moderate-to-Severe Atopic Dermatitis Patients Treated with Dupilumab

Long-term follow-up of recovered patients with COVID-19

(2021) Monica Cortinovis et al.   LANCET

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

(2020) Chaolin Huang et al.   LANCET

An interactive web-based dashboard to track COVID-19 in real time

(2020) Ensheng Dong et al.   LANCET INFECTIOUS DISEASES

Clinical Characteristics of Coronavirus Disease 2019 in China

(2020) Wei-jie Guan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Dupilumab and COVID ‐19: What should we expect?

(2020) Cataldo Patruno et al.   Dermatologic Therapy

Covid-19 and immunomodulation in IBD

(2020) Markus F Neurath   GUT

Safety of dupilumab in atopic patients during COVID-19 outbreak

(2020) Maddalena Napolitano et al.   JOURNAL OF DERMATOLOGICAL TREATMENT

Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biologic treatment and renal transplant recipients in maintenance immunosuppressive treatment

(2020) Paolo Gisondi et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

SARS‐CoV‐2 asymptomatic infection in a patient under treatment with dupilumab

(2020) Francesca Caroppo et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Safety of dupilumab in severe atopic dermatitis and infection of Covid‐19: two case reports

(2020) S. Ferrucci et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Elevated plasma level of selective cytokines in COVID-19 patients reflect viral load and lung injury

(2020) Yingxia Liu et al.   National Science Review

Is asthma protective against COVID‐19?

(2020) Giulia Carli et al.   ALLERGY

Management of adult patients with severe atopic dermatitis treated with dupilumab during COVID ‐19 pandemic: A single‐center real‐life experience

(2020) Mariateresa Rossi et al.   Dermatologic Therapy

Circulating levels of IL‐2, IL‐4, TNF‐α, IFN‐γ, and C‐reactive protein are not associated with severity of COVID‐19 symptoms

(2020) Wen Luo et al.   JOURNAL OF MEDICAL VIROLOGY

Risk of COVID-19 in dermatologic patients receiving long-term immunomodulatory therapy

(2020) Zachary E. Holcomb et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Longitudinal analyses reveal immunological misfiring in severe COVID-19

(2020) Carolina Lucas et al.   NATURE

Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers

(2020) Helen He et al.   Frontiers in Immunology

Risk factors for Covid-19 severity and fatality: a structured literature review

(2020) Dominik Wolff et al.   INFECTION

Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

(2019) Claus Bachert et al.   LANCET

Dupilumab Efficacy in Patients With Uncontrolled, Moderate-to-Severe Allergic Asthma

(2019) Jonathan Corren et al.   Journal of Allergy and Clinical Immunology-In Practice

Dupilumab progressively improves systemic and cutaneous abnormalities in atopic dermatitis patients

(2018) Emma Guttman-Yassky et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population

(2018) Zelma C. Chiesa Fuxench et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

A mild topical steroid leads to progressive anti-inflammatory effects in the skin of patients with moderate-to-severe atopic dermatitis

(2016) Patrick M. Brunner et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations

(2015) Stephen J. Teach et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Cyclosporine in patients with atopic dermatitis modulates activated inflammatory pathways and reverses epidermal pathology

(2014) Saakshi Khattri et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Progressive activation of TH2/TH22 cytokines and selective epidermal proteins characterizes acute and chronic atopic dermatitis

(2012) Julia K. Gittler et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Reversal of atopic dermatitis with narrow-band UVB phototherapy and biomarkers for therapeutic response

(2011) Suzanne Tintle et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Rhinovirus-induced lower respiratory illness is increased in asthma and related to virus load and Th1/2 cytokine and IL-10 production

(2008) S. D. Message et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA